In Vivo Screening Data Summary

NCI In Vivo Screening Data

P388 Leukemia resistant to Adriamycin; NSC 123127, Developed at Scr 08 (intraperitoneal) in CD2F1 (CDF1) mice

NSC 119875
CAS 15663-27-1
Cisplatin; Plantinol AQ; Cis-DDP

Chemical Data
Schedule (route) Endpoint Vehicle Dose Treated/Control (%) Observations
Q01DX005 (ip) median survival time saline 0.5 mg/kg/injection 181.0 Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 5
Q01DX005 (ip) median survival time saline 0.5 mg/kg/injection 141.0 Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5
Q01DX005 (ip) median survival time saline 1.0 mg/kg/injection 201.0 Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 5
Q01DX005 (ip) median survival time saline 1.0 mg/kg/injection 161.0 Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5
Q01DX005 (ip) median survival time saline 2.0 mg/kg/injection 202.0 Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 5
Q01DX005 (ip) median survival time saline 2.0 mg/kg/injection 217.0 Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5
Q01DX005 (ip) median survival time saline 4.0 mg/kg/injection 201.0 Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 5
Q01DX005 (ip) median survival time saline 4.0 mg/kg/injection 237.0 Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5
Q01DX005 (ip) median survival time saline 8.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 5
Q01DX005 (ip) median survival time saline 8.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5